257 related articles for article (PubMed ID: 29910095)
1. Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance (SLONM-MGUS): An alternative treatment using cyclophosphamide-thalidomide-dexamethasone (CTD) regimen.
Kumutpongpanich T; Owattanapanich W; Tanboon J; Nishino I; Boonyapisit K
Neuromuscul Disord; 2018 Jul; 28(7):610-613. PubMed ID: 29910095
[TBL] [Abstract][Full Text] [Related]
2. [Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance mimicking POEMS syndrome].
Kanamori T; Kusumoto S; Okita K; Hagiwara S; Kato C; Nakashima T; Murakami S; Narita T; Ito A; Ri M; Ishida T; Komatsu H; Matsukawa N; Iida S
Rinsho Ketsueki; 2018; 59(2):161-166. PubMed ID: 29515067
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory features in sporadic late-onset nemaline myopathy are independent from monoclonal gammopathy.
Tanboon J; Uruha A; Arahata Y; Dittmayer C; Schweizer L; Goebel HH; Nishino I; Stenzel W
Brain Pathol; 2021 May; 31(3):e12962. PubMed ID: 34043258
[TBL] [Abstract][Full Text] [Related]
4. Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance.
Uruha A; Benveniste O
Curr Opin Neurol; 2017 Oct; 30(5):457-463. PubMed ID: 28678037
[TBL] [Abstract][Full Text] [Related]
5. Rare myopathy associated to MGUS, causing heart failure and responding to chemotherapy.
Belhomme N; Maamar A; Le Gallou T; Minot-Myhié MC; Larralde A; Champtiaux N; Benveniste O; Leonard-Louis S; Decaux O; Lescoat A; Le Tulzo Y
Ann Hematol; 2017 Apr; 96(4):695-696. PubMed ID: 28058489
[No Abstract] [Full Text] [Related]
6. Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance: Report of four patients.
Okhovat AA; Nilipour Y; Boostani R; Vahabizad F; Najmi S; Nafissi S; Fatehi F
Neuromuscul Disord; 2021 Jan; 31(1):29-34. PubMed ID: 33308940
[TBL] [Abstract][Full Text] [Related]
7. A case of sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance: long-term observation of neurological symptoms after autologous stem-cell transplantation.
Ando T; Sato T; Kurahashi S; Kawaguchi Y; Kagaya Y; Ozawa Y; Hirano S; Goto Y; Mano K; Yokoi S; Nakamura T; Murakami A; Noda S; Kimura S; Sone J; Kuru S; Sobue G; Katsuno M
Nagoya J Med Sci; 2021 Aug; 83(3):641-647. PubMed ID: 34552296
[TBL] [Abstract][Full Text] [Related]
8. Sporadic Late-Onset Nemaline Myopathy: Current Landscape.
Nicolau S; Milone M
Curr Neurol Neurosci Rep; 2023 Nov; 23(11):777-784. PubMed ID: 37856049
[TBL] [Abstract][Full Text] [Related]
9. Sporadic late onset nemaline myopathy responsive to IVIg and immunotherapy.
Milone M; Katz A; Amato AA; Soderland CA; Segarceanu M; Young NP; Jones HR
Muscle Nerve; 2010 Feb; 41(2):272-6. PubMed ID: 19852026
[TBL] [Abstract][Full Text] [Related]
10. Sporadic late onset nemaline myopathy with monoclonal gammopathy of undetermined significance: two cases with long term stability.
Truffert A; Iancu Ferfoglia R; Lobrinus JA; Samii K; Kohler A
Eur J Transl Myol; 2020 Sep; 30(3):9225. PubMed ID: 33117509
[TBL] [Abstract][Full Text] [Related]
11. [Two cases of sporadic late onset nemaline myopathy effectively treated with immunotherapy].
Mizuno Y; Mori-Yoshimura M; Okamoto T; Oya Y; Nishino I; Murata M
Rinsho Shinkeigaku; 2016 Sep; 56(9):605-11. PubMed ID: 27580764
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic Profiles of Sporadic Late-Onset Nemaline Myopathy: Practical Importance of Anti-α-Actinin Immunostaining.
Zhao B; Dai T; Zhao D; Ma X; Zhao C; Li L; Sun Y; Zhang Y; Yan Y; Lu JQ; Liu F; Yan C
Neurol Neuroimmunol Neuroinflamm; 2022 Jul; 9(4):. PubMed ID: 35581006
[TBL] [Abstract][Full Text] [Related]
13. Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases.
Schnitzler LJ; Schreckenbach T; Nadaj-Pakleza A; Stenzel W; Rushing EJ; Van Damme P; Ferbert A; Petri S; Hartmann C; Bornemann A; Meisel A; Petersen JA; Tousseyn T; Thal DR; Reimann J; De Jonghe P; Martin JJ; Van den Bergh PY; Schulz JB; Weis J; Claeys KG
Orphanet J Rare Dis; 2017 May; 12(1):86. PubMed ID: 28490364
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal protein.
Kotchetkov R; Susman D; Bhutani D; Broch K; Dispenzieri A; Buadi FK
Int J Cancer; 2021 Jun; 148(11):2807-2814. PubMed ID: 33529362
[TBL] [Abstract][Full Text] [Related]
15. Impact of hematologic complete response in the treatment of sporadic late-onset nemaline myopathy associated with monoclonal gammopathy.
Maia T; Bergantim R; Costa H; Pinheiro J; Trigo F
Clin Case Rep; 2021 Jul; 9(7):e04471. PubMed ID: 34295490
[TBL] [Abstract][Full Text] [Related]
16. [Sporadic Late-Onset Nemaline Myopathy Associated with MGUS].
Nagai T; Sunada Y
Brain Nerve; 2015 Dec; 67(12):1515-21. PubMed ID: 26618766
[TBL] [Abstract][Full Text] [Related]
17. Sporadic late-onset nemaline myopathy with MGUS: long-term follow-up after melphalan and SCT.
Voermans NC; Benveniste O; Minnema MC; Lokhorst H; Lammens M; Meersseman W; Delforge M; Kuntzer T; Novy J; Pabst T; Bouhour F; Romero N; Leblond V; Bergh Pv; Vekemans MC; van Engelen BG; Eymard B
Neurology; 2014 Dec; 83(23):2133-9. PubMed ID: 25378674
[TBL] [Abstract][Full Text] [Related]
18. Sporadic late onset nemaline myopathy and immunoglobulin deposition disease.
Doppler K; Knop S; Einsele H; Sommer C; Wessig C
Muscle Nerve; 2013 Dec; 48(6):983-8. PubMed ID: 23873431
[TBL] [Abstract][Full Text] [Related]
19. Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort.
Monforte M; Primiano G; Silvestri G; Mirabella M; Luigetti M; Cuccagna C; Ricci E; Servidei S; Tasca G
J Neurol; 2018 Mar; 265(3):542-551. PubMed ID: 29356967
[TBL] [Abstract][Full Text] [Related]
20. [Treatability of sporadic late onset nemaline myopathy].
Hanisch F; Schneider I; Müller T; Romeike BF; Stoltenburg G; Holzhausen HJ; Zierz S
Nervenarzt; 2013 Aug; 84(8):955-61. PubMed ID: 23836301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
